BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Newcastle Hospitals Clinical Skills Academy - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Newcastle Hospitals Clinical Skills Academy
X-ORIGINAL-URL:https://skillsacademy.newcastle-hospitals.nhs.uk
X-WR-CALDESC:Events for Newcastle Hospitals Clinical Skills Academy
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260317T133000
DTEND;TZID=Europe/London:20260324T163000
DTSTAMP:20260421T162527
CREATED:20250922T141230Z
LAST-MODIFIED:20250922T164722Z
UID:10000128-1773754200-1774369800@skillsacademy.newcastle-hospitals.nhs.uk
SUMMARY:Targeted treatments and immunotherapy for Breast Cancer
DESCRIPTION:Delivered over two\, two-hour sessions\, Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – will guide you through many of the most relevant topics relating to modern systemic treatments for breast cancer. \nElaine first looks at why cancers arise – through the accumulation of gene mutations affecting important genes. She also looks at other vital factors in breast cancer – hormones\, and the vigilance of the person’s immune system and also looks at the challenges we face in classifying breast cancer and the reasons why breast cancer might spread to other parts of the body. \nElaine then dives into the mechanisms of action of hormone therapies for breast cancer and looks at new treatments being developed. \nIn the second session\, Elaine looks at HER2-positive and triple-negative breast cancer. She explains what HER2 is\, and what features make it an almost-ideal target for treatments. After describing various such treatments\, Elaine explains why resistance can happen and how it might be overcome. \nElaine then discusses triple-negative breast cancer\, which is\, in fact\, a diverse group of diseases. She describes the progress made to date in developing more effective treatments. \nAudience\nDr Vickers’ goal is to explain the science that underpins each treatment. She also hopes to provide learners with a broad understanding of why treatments work well for some patients but not for others. \nThis half day course is ideal for research nurses\, clinical nurse specialists\, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with breast cancer\, and to junior doctors. \nACCEND\nNHS England’s ACCEND Programme aims to support the development of a skilled and knowledgeable cancer workforce. \nThis course supports Component 3 of the ACCEND pathway\, the Education Framework. \nSpecifically\, this course’s objectives and learning outcomes meet core cancer knowledge needs at both the ‘Foundation of Cancer Care’ and ‘Fundamentals of Cancer Care’ levels. \nThe course will enhance learners’ understanding of cancer biology\, the mechanism of action of systemic cancer treatments\, and the use of biomarkers to select the best treatments for each patient. \nThe knowledge gained through this course will empower staff to feel confident when communicating with patients and their families\, and with clinical and non-clinical colleagues. \nDetailed description\nSession 1\nPresentation 1 – Introduction to breast cancer \n\nHow breast cancer arises\nWho’s most at risk?\nHow should we classify breast cancer?\nCommon mutations in breast cancer cells\nHow\, when and why breast cancer spreads\nWho’s at risk of their cancer returning\n\nPresentation 2 – Treatments for hormone receptor-positive breast cancer \n\nHormone receptors and hormone therapies\nWhy combine hormone therapy with CDK inhibitors?\nCauses of resistance to hormone therapies\nTargeting the PI3K/AKT/mTOR pathway\nNovel hormone therapies: SERDs and PROTACs\n\nSession 2\nPresentation 3 – Treatments for HER2-positive breast cancer \n\nWhat is HER2?\nTargeting HER2\nAntibody-based treatments – naked antibodies and antibody-drug conjugates\nHER2-targeted kinase inhibitors\nOvercoming resistance to HER2-targeted treatments\nHER2-low breast cancer\n\nPresentation 4 – Treatments for triple-negative breast cancer \n\nIntroduction to triple-negative breast cancer\nImmunotherapy with checkpoint inhibitors\nSacituzumab govitecan and other antibody-drug conjugates\nPARP inhibitors for BRCA-mutated breast cancer\n\nPre-course preparation\nElaine has created two YouTube playlists about cancer biology and cancer treatments to help learners get the most out of her courses. Each playlist contains 10 videos between 3 and 8 minutes long. \nElaine also advises: “If you’re short on time and you’re not sure about the relationship between DNA\, genes and proteins\, I would suggest watching the Cells\, DNA\, genes and chromosomes and From genes to proteins videos from the Cancer Basics playlist as a priority. Also\, if you’re new to cancer\, I’d recommend the Mutations cause cancer video and\, in order to understand how cancer cells interact with the cells around them\, watch the Tumours are complicated places video.” \n“In the Cancer Treatments playlist\, there are videos about all the various treatments I’ll be mentioning. The two I’d prioritise explain why we use small chemical compounds (small molecules) and antibodies as cancer treatments. If you have more time\, do also watch the videos on kinase inhibitors and immune checkpoint inhibitors.” \nAbout Elaine Vickers\nDr Elaine Vickers\nElaine Vickers of Science Communicated Ltd has a PhD in Molecular Biology. She has worked as a cancer educator for over twenty years. \nShe is passionate about demystifying the science behind cancer biology and the latest cancer treatments such as kinase inhibitors\, monoclonal antibodies\, and immunotherapies. \nElaine is experienced in teaching people with any level of scientific or medical knowledge. She particularly loves teaching nurses and other health professionals who might feel daunted by the idea of learning about cancer science. \nHer book\, A Beginner’s Guide to Targeted Cancer Treatments and Cancer Immunotherapy\, is now in its second edition. The first edition was Highly Commended by the British Medical Association book awards. \nElaine also makes short educational videos on cancer biology and treatments\, which you can find on her YouTube channel: https://www.youtube.com/@DrElaineVickers
URL:https://skillsacademy.newcastle-hospitals.nhs.uk/course/targeted-treatments-and-immunotherapy-for-breast-cancer/
LOCATION:Virtual delivery via MS Teams
CATEGORIES:Cancer courses
ATTACH;FMTTYPE=image/jpeg:https://skillsacademy.newcastle-hospitals.nhs.uk/wp-content/uploads/2024/09/3D-graphic-image-of-breast-banner-scaled.jpg
ORGANIZER;CN="Newcastle Hospitals Skills Academy":MAILTO:nuth.newcastlehospitalsskillsacademy@nhs.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260210T133000
DTEND;TZID=Europe/London:20260210T163000
DTSTAMP:20260421T162527
CREATED:20250923T133528Z
LAST-MODIFIED:20260209T114325Z
UID:10000127-1770730200-1770741000@skillsacademy.newcastle-hospitals.nhs.uk
SUMMARY:Targeted treatments and immunotherapy for Upper GI Cancers
DESCRIPTION:In this half-day course\, Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – provides an overview of the targeted therapies and immunotherapies given to some people with oesophageal\, stomach\, pancreatic or liver cancer\, or cancers of the biliary system. \nElaine first looks briefly at the gene mutations and faulty processes and pathways that give rise to upper GI cancers and the factors that increase a person’s risk of these diseases. \nShe then turns her attention to the targeted treatments and immunotherapies that are relevant to oesophageal\, gastroesophageal junction\, stomach\, biliary\, liver\, and pancreatic cancer. \nCheckpoint inhibitor therapy is now used widely\, but it isn’t useful against every form of cancer. Elaine looks at why this is the case and why it is largely ineffective against pancreatic cancer. \nElaine will also describe various treatments that target mutated proteins found in cancer cells\, such as HER2\, FGFR\, and IDH1\, and the progress made to date in targeting Claudin 18.2. \nLastly\, Elaine will explain why pancreatic cancer is so difficult to treat and describe two promising strategies: personalised vaccines and Ras protein inhibitors. \nAudience \nThis is a wide-ranging course with lots to cover. Rather than providing a detailed description of the diseases\, Elaine’s focus is on the treatments: how they work\, why they are given to some patients and not others\, and what other treatments are being developed. \nThis course is ideal for research nurses\, clinical nurse specialists\, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with upper GI cancers. \nACCEND\nNHS England’s ACCEND Programme aims to support the development of a skilled and knowledgeable cancer workforce. \nThis course supports Component 3 of the ACCEND pathway\, the Education Framework. \nSpecifically\, this course’s objectives and learning outcomes meet core cancer knowledge needs at both the ‘Foundation of Cancer Care’ and ‘Fundamentals of Cancer Care’ levels. \nThe course will enhance learners’ understanding of cancer biology\, the mechanism of action of systemic cancer treatments\, and the use of biomarkers to select the best treatments for each patient. \nThe knowledge gained through this course will empower staff to feel confident when communicating with patients and their families\, and with clinical and non-clinical colleagues. \nDetailed description\nPresentation 1 – Introduction to targeted therapies and immunotherapies for upper GI cancers \n\nAn overview of the faulty genes\, pathways\, and processes that cause cancer\nIntroduction to targeted therapy with antibody-based treatments and kinase inhibitors\nThe relationship between cancer and the immune system\nIntroduction to immunotherapy\n\nPresentation 2 – Treating upper GI cancers with checkpoint inhibitor immunotherapy \n\nHow checkpoint inhibitors work\nBiomarkers of response and resistance\nCombinations\nTiming – advanced vs. early; adjuvant vs. neoadjuvant\n\nPresentation 3 – Targeted therapies for oesophageal\, GEJ\, stomach and liver cancer \n\nHER2-targeted therapies for gastric/GEJ cancers\nFGFR-targeted therapies for gastric/GEJ cancers and cholangiocarcinoma\nTargeting IDH1 in cholangiocarcinoma\nTargeting CLDN18.2 with antibody-based treatments for gastric/GEJ cancers\n\nWhat’s happening with pancreatic cancer? \n\nA perfect storm – the genetic\, molecular and cellular makeup of pancreatic cancer\nPancreatic cancer – targeted treatment approaches and immunotherapies that have been tried and failed\nHow can we make progress against pancreatic cancer?\n\nPre-course preparation\nElaine has created two YouTube playlists about cancer biology and cancer treatments to help learners get the most out of her courses. Each playlist contains 10 videos between 3 and 8 minutes long. \nElaine advises “If you’re short on time and you’re not sure about the relationship between DNA\, genes and proteins\, I would suggest watching the Cells\, DNA\, genes and chromosomes and From genes to proteins videos from the Cancer Basics playlist as a priority. Also\, if you’re new to cancer\, I’d recommend the Mutations cause cancer video and\, in order to understand how cancer cells interact with the cells around them\, watch the Tumours are complicated places video.” \n“In the Cancer Treatments playlist\, there are videos about all the various treatments I’ll be mentioning. The two I’d prioritise explain why we use small chemical compounds (small molecules) and antibodies as cancer treatments. If you have more time\, do also watch the videos on kinase inhibitors and immune checkpoint inhibitors.” \nAbout Elaine Vickers\nDr Elaine Vickers\nElaine Vickers of Science Communicated Ltd has a PhD in Molecular Biology. She has worked as a cancer educator for over twenty years. \nShe is passionate about demystifying the science behind cancer biology and the latest cancer treatments such as kinase inhibitors\, monoclonal antibodies\, and immunotherapies. \nElaine is experienced in teaching people with any level of scientific or medical knowledge. She particularly loves teaching nurses and other health professionals who might feel daunted by the idea of learning about cancer science. \nHer book\, A Beginner’s Guide to Targeted Cancer Treatments and Cancer Immunotherapy\, is now in its second edition. The first edition was Highly Commended by the British Medical Association book awards. \nElaine also makes short educational videos on cancer biology and treatments\, which you can find on her YouTube channel: https://www.youtube.com/@DrElaineVickers
URL:https://skillsacademy.newcastle-hospitals.nhs.uk/course/targeted-treatments-and-immunotherapy-for-upper-gi-cancers/
LOCATION:Virtual delivery via MS Teams
CATEGORIES:Cancer courses
ATTACH;FMTTYPE=image/jpeg:https://skillsacademy.newcastle-hospitals.nhs.uk/wp-content/uploads/2025/09/Upper-GI-Cancer-edit.jpg
ORGANIZER;CN="Newcastle Hospitals Skills Academy":MAILTO:nuth.newcastlehospitalsskillsacademy@nhs.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260113T133000
DTEND;TZID=Europe/London:20260113T163000
DTSTAMP:20260421T162527
CREATED:20250922T131905Z
LAST-MODIFIED:20251217T094324Z
UID:10000126-1768311000-1768321800@skillsacademy.newcastle-hospitals.nhs.uk
SUMMARY:Targeted treatments and immunotherapy for Bowel Cancer
DESCRIPTION:Delivered over one afternoon session\, Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – provides an up-to-date overview of modern systemic treatment approaches given to people with bowel cancer including treatment combinations and new approaches currently being investigated in clinical trials. \nElaine first of all looks at the gene mutations and faulty processes and pathways that give rise to bowel cancer\, explaining the relationship between mismatch repair deficiency (dMMR) and microsatellite instability (MSI). \nShe then turns her attention to antibodies that target the EGF receptor (EGFR) and also summarises why they’re only effective for some people and looks at various reasons for resistance. \nCheckpoint inhibitor therapy has recently given highly promising results in trials\, but only if the tumour is dMMR/MSI. Elaine will describe why this is\, and explore whether immunotherapy might still hold promise for people whose cancers don’t display this characteristic. \nLastly\, Elaine will look at other targeted therapies and immunotherapies that have shown recent promise in trials. These include drugs that target B-Raf\, HER2 and Ras proteins. \nAudience\nDr Vickers’ goal is to explain the science that underpins each treatment. She also hopes to provide learners with a broad understanding of why treatments work well for some patients but not for others. \nThis half day course is ideal for research nurses\, clinical nurse specialists\, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with bowel cancer\, and to junior doctors. \nACCEND\nNHS England’s ACCEND Programme aims to support the development of a skilled and knowledgeable cancer workforce. \nThis course supports Component 3 of the ACCEND pathway\, the Education Framework. \nSpecifically\, this course’s objectives and learning outcomes meet core cancer knowledge needs at both the ‘Foundation of Cancer Care’ and ‘Fundamentals of Cancer Care’ levels. \nThe course will enhance learners’ understanding of cancer biology\, the mechanism of action of systemic cancer treatments\, and the use of biomarkers to select the best treatments for each patient. \nThe knowledge gained through this course will empower staff to feel confident when communicating with patients and their families\, and with clinical and non-clinical colleagues. \nDetailed description\nPresentation 1 – Biology and genetics of bowel cancer \n\nCell of origin and mechanisms of development\nThe tumour microenvironment\nKey mutations and defective pathways and proteins in bowel cancer cells\nExplaining the relationship between mismatch repair deficiency (MMRd)\, microsatellite instability (MSI) and CPG-island methylator phenotype (CIMP)\n\nPresentation 2 – Targeting the EGFR in bowel cancer \n\nHow cells communicate using growth factor receptor-controlled signalling pathways\nThe normal function of EGFR (epidermal growth factor receptor)\nMechanisms of action of EGFR-targeted antibodies\nWho benefits from EGFR-targeted antibodies?\nKRAS mutation testing and left sided vs. right sided bowel cancers\nShould we be doing more testing?\n\nPresentation 3 – More targets and treatments for bowel cancer \n\nAngiogenesis inhibitors\nImmunotherapy for people with MMR-deficient/MSI bowel cancer\nImmunotherapy for people with MMR-proficient bowel cancer\nB-Raf inhibitor combinations for people with BRAF-mutated tumours\nTargeting HER2\, mutant K-Ras\, and Trk proteins\n\nPre-course preparation\nElaine has created two YouTube playlists about cancer biology and cancer treatments to help learners get the most out of her courses. Each playlist contains 10 videos between 3 and 8 minutes long. \nElaine advises “If you’re short on time and you’re not sure about the relationship between DNA\, genes and proteins\, I would suggest watching the Cells\, DNA\, genes and chromosomes and From genes to proteins videos from the Cancer Basics playlist as a priority. Also\, if you’re new to cancer\, I’d recommend the Mutations cause cancer video and\, in order to understand how cancer cells interact with the cells around them\, watch the Tumours are complicated places video.” \n“In the Cancer Treatments playlist\, there are videos about all the various treatments I’ll be mentioning. The two I’d prioritise explain why we use small chemical compounds (small molecules) and antibodies as cancer treatments. If you have more time\, do also watch the videos on kinase inhibitors and immune checkpoint inhibitors.” \nAbout Elaine Vickers\nDr Elaine Vickers\nElaine Vickers of Science Communicated Ltd has a PhD in Molecular Biology. She has worked as a cancer educator for over twenty years. \nShe is passionate about demystifying the science behind cancer biology and the latest cancer treatments such as kinase inhibitors\, monoclonal antibodies\, and immunotherapies. \nElaine is experienced in teaching people with any level of scientific or medical knowledge. She particularly loves teaching nurses and other health professionals who might feel daunted by the idea of learning about cancer science. \nHer book\, A Beginner’s Guide to Targeted Cancer Treatments and Cancer Immunotherapy\, is now in its second edition. The first edition was Highly Commended by the British Medical Association book awards. \nElaine also makes short educational videos on cancer biology and treatments\, which you can find on her YouTube channel: https://www.youtube.com/@DrElaineVickers
URL:https://skillsacademy.newcastle-hospitals.nhs.uk/course/targeted_treatments_immunotherapy_bowel_cancer/
LOCATION:Virtual delivery via MS Teams
CATEGORIES:Cancer courses
ATTACH;FMTTYPE=image/jpeg:https://skillsacademy.newcastle-hospitals.nhs.uk/wp-content/uploads/2025/09/Bowel-Cancer.jpg
ORGANIZER;CN="Newcastle Hospitals Skills Academy":MAILTO:nuth.newcastlehospitalsskillsacademy@nhs.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251209T133000
DTEND;TZID=Europe/London:20251216T163000
DTSTAMP:20260421T162527
CREATED:20250918T091424Z
LAST-MODIFIED:20251201T113151Z
UID:10000124-1765287000-1765902600@skillsacademy.newcastle-hospitals.nhs.uk
SUMMARY:Introduction to the Science of Systemic Cancer Treatments and Cancer Biomarkers
DESCRIPTION:Delivered over two afternoon sessions\, Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – will introduce learners to the main groups of systemic cancer treatments and describe how they work. She will then explain how biomarker tests can be used to select the right treatment for each patient. \nFirst session: Elaine provides an overview of the mechanisms of action of chemotherapy\, hormone therapy\, targeted therapy\, and immunotherapy. She describes why we use antibodies and kinase inhibitors to treat cancer and explains why so many of these treatments target cell communication. \nShe also briefly describes antibody-drug conjugates and provides an overview of immunotherapies for solid tumours and haematological cancers. \nSecond session:  Elaine introduces biomarkers by describing what they are\, where they are found\, and how they can be used. She then provides examples of the biomarkers currently used to select treatments for patients\, focusing on their applications in lung cancer\, breast cancer\, and melanoma skin cancer. \nNext up\, Elaine looks at what the future might hold for precision medicine in bowel and pancreatic cancer. In the final section. She will explore the possibility of using cancer DNA isolated from the blood as a method for detecting cancers before they cause symptoms. \nAudience \nThis course is ideal for clinical staff who may be new to caring for cancer patients including staff nurses\, pharmacists and clinical trials coordinators\, and is also suitable for anyone involved in cancer research and trials. \nElaine’s goal is to explain the science in an interesting and accessible way\, providing learners with a broad understanding that they can build on in the future. She will use colourful illustrations and jargon-free explanations to help learners gain a broad understanding of the concepts covered. \nACCEND\nNHS England’s ACCEND Programme aims to support the development of a skilled and knowledgeable cancer workforce. \nThis course supports Component 3 of the ACCEND pathway\, the Education Framework. \nSpecifically\, this course’s objectives and learning outcomes meet core cancer knowledge needs at both the ‘Foundation of Cancer Care’ and ‘Fundamentals of Cancer Care’ levels. \nThe course will enhance learners’ understanding of cancer biology\, the mechanism of action of systemic cancer treatments\, and the use of biomarkers to select the best treatments for each patient. \nThe knowledge gained through this course will empower staff to feel confident when communicating with patients and their families\, and with clinical and non-clinical colleagues. \nDetailed description \nSession One: Tuesday 9th December 2025 – 1:30 – 4:30pm\nPresentation 1 – Cancer biology\, chemotherapy and hormone therapies \n\nCells\, DNA\, genes and proteins\nDNA damage as the cause of cancer\nWhat is chemotherapy how does it work?\nWhy so many different drugs\, and why are they often given in combinations?\nHow does hormone therapy work?\nHormone therapy for breast cancer and prostate cancer\n\nPresentation 2 – Targeted therapies \n\nWhat does the term ‘targeted therapy’ actually mean?\nWhat do these drugs target?\nIntroducing monoclonal antibodies\, kinase inhibitors & other small molecules\nWho are they given to\, and why aren’t they given to everyone?\nWhy don’t they always work\, and why do people’s cancers come back?\n\nPresentation 3 – Immunotherapy \n\n What is immunotherapy?\nHow can our immune system destroy cancer cells?\nHow do immunotherapies work\, and why don’t they work for everyone?\nAre immunotherapies for solid tumours and blood cancers the same?\n\nSession Two: Tuesday 16th December 2025 – 1:30 – 4:30pm\nPresentation 4 – Introduction to biomarkers \n\nWhat does the term ‘biomarker’ mean\, and what are they used for?\nWhere do we find them? (e.g. biopsies\, aspirates\, blood samples)\nWhat testing methods and measurements do we use? (e.g. genetic testing\, immunohistochemistry\, whole genome sequencing\, commercial platforms)\n\nPresentation 5 – Precision cancer medicine – where are we now? \n\nPrecision medicine for non-small cell lung cancer: PD-L1\, EGFR\, ALK\, ROS1\, RET\, MET\, other mutations\nPrecision medicine for breast cancer: testing for hormone receptors\, HER2 amplification\, PIK3CA/ATK/PTEN & ESR1 mutations\nPrecision medicine for melanoma skin cancer: testing for BRAF mutations\n\nPresentation 6 – Precision cancer medicine – where are we heading? \n\nAdvances in precision medicine for bowel cancer\nWhat’s the future of precision medicine for pancreatic cancer?\nCan we diagnose cancer earlier using blood samples?\n\nPre-course preparation\nElaine has created two YouTube playlists about cancer biology and cancer treatments to help learners get the most out of her courses. Each playlist contains 10 videos of between 3 and 8 minutes. \nElaine has also given this advice: “If you’re short on time and you’re not sure about the relationship between DNA\, genes and proteins\, I would suggest watching the Cells\, DNA\, genes and chromosomes and From genes to proteins videos from the Cancer Basics playlist as a priority. If you’re new to cancer I’d also recommend the Mutations cause cancer video.” \n“In the Cancer Treatments playlist\, there are videos about all the various treatments I’ll be mentioning in the first session. The two I’d prioritise explain why we use small chemical compounds (small molecules) and antibodies as cancer treatments.” \nAbout Elaine Vickers\nDr Elaine Vickers\nElaine Vickers of Science Communicated Ltd has a PhD in Molecular Biology. She has worked as a cancer educator for over twenty years. \nShe is passionate about demystifying the science behind cancer biology and the latest cancer treatments such as kinase inhibitors\, monoclonal antibodies\, and immunotherapies. \nElaine is experienced in teaching people with any level of scientific or medical knowledge. She particularly loves teaching nurses and other health professionals who might feel daunted by the idea of learning about cancer science. \nHer book\, A Beginner’s Guide to Targeted Cancer Treatments and Cancer Immunotherapy\, is now in its second edition. The first edition was Highly Commended by the British Medical Association book awards. \nElaine also makes short educational videos on cancer biology and treatments\, which you can find on her YouTube channel: https://www.youtube.com/@DrElaineVickers \nFinancial information\nIf you are employed by Newcastle Hospitals NHS Foundation Trust\, you can use the coupon code NUTH at the checkout to make a provisional booking and you will need to arrange access to in-house development funding. Your booking will remain provisional until your request has been validated with a funding/study leave reference. \nIf you are not employed by the Newcastle Hospitals an online card payment is required at the point of booking. Alternatively\, if you are to be funded by your employer an invoice can be requested by using the coupon code Invoice. \nIf you are a LET employee you will need to pay by card as we are unable to invoice LETs. \nPlease see Coupons for further information relating to coupon codes and how to use them at checkout. \nCancellation and refunds policy\nShould you no longer be able to attend the event on the booked date\, please contact the Academy as we may be able to offer an alternative date subject to an admin charge. \nShould you still wish to cancel your booking\, you or your employer will be charged as per the fees outlined below.  Please contact nuth.newcastlehospitalsskillsacademy@nhs.net to cancel your booking. \n\n\n\nTimescale\nFee paying course\n\n\nOver 6 weeks\n£25 admin charge\n\n\n2 to 6 weeks\n50% of course fee\n\n\n0 to 2 weeks\n100% of course fee\n\n\n\nIf you do not attend on the day\, you will be charged the full cost of the event place. \nSee our Terms & Conditions and Cancellations & Refunds pages for more details.
URL:https://skillsacademy.newcastle-hospitals.nhs.uk/course/introduction-to-the-science-of-systemic-cancer-treatments-and-biomarkers/
LOCATION:Virtual delivery via MS Teams
CATEGORIES:Cancer courses
ATTACH;FMTTYPE=image/jpeg:https://skillsacademy.newcastle-hospitals.nhs.uk/wp-content/uploads/2025/09/Systemic-and-Targeted-Treatments-for-Cancer-e1758559562227.jpg
ORGANIZER;CN="Newcastle Hospitals Skills Academy":MAILTO:nuth.newcastlehospitalsskillsacademy@nhs.net
END:VEVENT
END:VCALENDAR